Hearing Aid Price List
CIC/ITC/ITE
- Digital Hearing Aids
- Analog Hearing Aids
BTE
Necklace hearing aid
- Digital Hearing Aids
- Analog Hearing Aids
Special Hearing Aid
- Spectacle Hearing Aid
- FM Wireless
- Bluetooth Hearing Aid
- Magnetic Field Type
- Tinnitus Treatment Type
Accessory
 
CIC/ITC/ITE Hearing Aids Home > Products > CIC/ITC/ITE > Digital Hearing Aids
 
 
Clear Z CIC Clear Z ITC Clear Z ITE
 
 
Clear U2 Clear U9/V Clear E
 
 
Clear D/G Clear C Clear K2, K8
 
 

Digital Hearing Aids

 
 
Clear U2
  hearing aid providing optimal and comfortable sound with
  real time statistical analysis through 32 independent channels.
  - Statistical analysis through 32 independent channels
  - Reduction of background noise using directional technology
  - Automatic directional attributes through real time noise environmental
    analysis
  - Automatic adaptive feedback cancellation
  - Automation adaptive noise reduction
  - Includes all functions of Clear C.

 

New conceptual hearing aid for customers who want a premium product to listen to comfortable music.
The hearing aid Clear U2 is an alternative solution for those who are not satisfied with a digital hearing aid in case of listening to music. We offer special price of KRW 2.5 million.
Retail price: KRW 3.28 million
Optional
- Acoustic vent (minimization of ear occuluded effects. KRW 100,000 added)
- Volume controller (for customers who need frequent volume control)
- Microphone (Directional function)
- Memory switch button

 
 
(Fitting Range)
    Peak OSPL90    ¡Â116 dB SPL ±3dB
    HFA OSPL90    113 dB SPL ±5dB
    Peak full-on gain    34 dB ±5dB
    HFA full-on gain    30dB ±5dB
    Frequency range    200Hz - 6500Hz
    Equivalent input noise level    ¡Â29 dB +3dB
    Battery current drain    ¡Â1.2mA +20%
    Estimated battery life    ¡Ã48 hours or more
   (when using 10A zinc-air)
    Total harmonic distortion    500Hz ¡Â3.0% +3%,
   800Hz ¡Â3.0% +3%,
   1600Hz ¡Â3.0% +3%
    Rated voltage    DC 1.4V
 

Deliberation completed by the Medical Equipment Pre-Deliberation Committee of Korea Food and Drug Administration
(2007-I10-04-0018)